Becton Dickinson And's Revenue in the fiscal year 2025 $ 21,840.00 millions
Becton Dickinson And's Revenue in the fiscal year 2024 $ 20,178.00 millions
Becton Dickinson And's Revenue in the fiscal year 2023 $ 19,372.00 millions
Becton Dickinson And's Revenue in the fiscal year 2022 $ 18,870.00 millions
Becton Dickinson And's Revenue in the fiscal year 2021 $ 20,248.00 millions
BDX Revenue third quarter 2026 Y/Y Growth Comment
Becton Dickinson And Company reported Revenue growth of 5.44% year on year in the third quarter 2026, to $ 4,983.00 millions, this is lower than Becton Dickinson And Company's recent average Revenue growth of 7.47%.
Looking into third quarter 2026 results within Medical Equipment & Supplies industry 152 other companies have achieved higher Revenue growth. While Becton Dickinson And Company' s Revenue increase of 5.44% ranks overall at the positon no. 3315 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Becton Dickinson And's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
52.12 %
1.92 %
-10.85 %
(Jun 30 2015)
BDX's III. Quarter Q/Q Revenue Comment
Becton Dickinson And Company achieved in the III. Quarter 2026 above company average sequential Revenue increase of 5.71%, to $ 4,983.00 millions, from $4,714.00 millions in the second quarter. BDX is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 43 other companies have achieved higher Revenue quarter on quarter growth. While Becton Dickinson And's Revenue growth quarter on quarter, overall rank is 1091.
Becton Dickinson And Company achieved in the III. Quarter 2026 above company average sequential Revenue increase of 5.71%, to $ 4,983.00 millions, from $4,714.00 millions in the second quarter. BDX is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 43 other companies have achieved higher Revenue quarter on quarter growth. While Becton Dickinson And's Revenue growth quarter on quarter, overall rank is 1091.
Becton Dickinson And's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 20,840.00
$ 20,583.00
$ 20,349.00
$ 20,265.00
$ 19,811.00
Y / Y Revenue Growth (TTM)
5.19 %
2.53 %
-1.41 %
0.43 %
-0.09 %
Year on Year Revenue Growth Overall
Ranking
# 1956
# 1332
# 227
# 1613
# 968
Seqeuential Revenue Change (TTM)
1.25 %
1.15 %
0.41 %
2.29 %
-1.32 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2498
# 1724
# 283
# 1851
# 1545
Cumulative Revenue growth Comment
Although Becton Dickinson And's Annual Revenue growth year on year were below company's average 7.52% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 5.19% year on year, from 2.53% in Mar 31 2026.
In the Healthcare sector 304 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1332 to 1956.
Although Becton Dickinson And's Annual Revenue growth year on year were below company's average 7.52% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 5.19% year on year, from 2.53% in Mar 31 2026.
In the Healthcare sector 304 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1332 to 1956.
About Becton Dickinson And Revenue Growth Rates (BDX), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
9.45%